FDA Approves Fibrocell’s laViv
FDA Approves Fibrocell’s laViv
Chester County KIZ Company, Fibrocell Science Inc. was featured in the Business section of the Daily Local News Thursday as they recieved Food and Drug Administration approval for their new wrinkle treatment technology called laViv. laViv’s revolutionary technology uses a patient’s own collagen-making cells to help treat nasolabial fold wrinkles and restore appearance over time.
Visit the Daily Local News website to view a complete article on Fibrocell and laViv.
Evolve IP Technology Assistance Grant
Evolve IP is offering eligible KIZ Companies a Technology Assistance Grant to help with the progress of business productivity.
For more information please refer to the attached flyer from Evolve IP.
DINNIMAN ANNOUNCES TAX CREDITS FOR LOCAL LIFE SCIENCE FIRMS
WEST CHESTER (December 15) – State Senator Andy Dinniman said seven cutting-edge Chester County life science firms have been awarded a total of nearly $600,000 in tax credits from the state program that assists companies with great growth and job-creation potential.
Pennsylvania’s Department of Community and Economic Development on Wednesday announced Keystone Innovation Zone tax credits for the following firms:
- Alliance Pharma, Inc., will receive $100,000 in KIZ tax credits. Alliance Pharma, of Malvern, was founded in 2007 and provides life-science research for its clients.
- Frontage Laboratories, Inc., will receive $100,000 in KIZ tax credits. Frontage Laboratories, of Exton, was founded in 2001 and provides pharmaceutical research and development services.
- Molecular Targeting Technologies, Inc., will receive $100,000 in KIZ tax credits. Molecular Targeting Technologies, of West Goshen, began in 2001. It is a biotechnology company specializing in the molecular imaging of diseases.
- Neuronetics will receive $100,000 in KIZ tax credits. Neuronetics, of Malvern, incorporated in 2003. It is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders.
- Progenra will receive $69,473 in KIZ tax credits. Progenra, of Malvern, was founded in 2002. It develops new medicines for diseases including cancer and osteoporosis.
- Shifa Biomedical will receive $100,000 in KIZ tax credits. Shifa Biomedical, of Malvern, started in 2005. It is a biopharmaceutical company that develops drugs for prostate cancer and cardiovascular disease.
- Y-Prime will receive $24,247 in KIZ tax credits. Y-Prime, of Malvern, started in 2006. It is a pharmaceutical consulting business.
“These young, start-up companies already offer highly skilled, good-paying jobs and are a vital part of Chester County’s economy,” said Dinniman. “Just as importantly, some of today’s up-and-comers will become tomorrow’s industry leaders and provide county residents with vital economic opportunities in this increasingly competitive job market.”
“The Keystone Innovation Zone program helps ensure that promising, young companies with tremendous growth potential set their roots right here in Pennsylvania rather than someplace else.It’s good to see Chester County taking full advantage of this important economic development tool,” Dinniman said.
For more details, contact Martin Indars in Senator Dinniman’s office at 1-610-692-2112 or at mindars@pasenate.com.
GreenPointe.Energy Helps Local Organizations Hedge Rising Energy Market
COATESVILLE, PENNSYLVANIA; July 2010 – GreenPointe.Energy orchestrates energy procurement contract for Lambert Spawn. Jason Ulshafer, president, announced that Exelon has secured the winning bid out of seven other competing suppliers.
Greenpointe.Energy has helped Lambert Spawn, a local mushroom farm, secure a long term energy contract. GreenPointe.Energy, using a new and advanced online auction platform, conducted the auction at 10:30 AM on July 1st. The auction closed at 11:30 AM. Because of the auction held by GreenPointe.Energy, Lambert Spawn will secure a better price for the 5 million kilowatt hours the county uses annually, resulting in immediate savings.
Holding these types of auctions helps companies preempt the pending deregulation and electric rate increases that will take effect January 1st, 2011. Lambert Spawn has successfully hedged rising energy costs in PECO territory which experts say will prevent a rising 10 to 20 percent increase in energy costs come January 1st, 2011.
About GreenPointe.Energy
GreenPointe.Energy is a single point of entry solution provider specializing in renewable energy development, energy procurement and energy management technologies.
Contact Info: info@greenpointeenergy.com
GreenPointe.Energy Begins Solar Construction on Crystal Springs Distribution center
EXTON, PENNSYLVANIA; July 2010—GreenPointe.Energy began construction of a solar energy system on the Crystal Spring Distribution Center in Exton, Pennsylvania on July 1, 2010. The Hankin Group, also of Exton, PA, are the owners of the Distribution Center.
The Hankin Group engaged GreenPointe.Energy to provide a turnkey solution for this solar PV system. The project includes comprehensive engineering and design, installation, and commissioning of the system. GreenPointe. Energy’s services also provide all project management, SREC assignment, financing, administration and logistics.
This 166 kilowatt system, once completed, will reduce monthly electricity bills up to 93%. Over a 25 year span, the system will see savings grow by 220%. This amounts to 3,421 tons of carbon dioxide being eliminated.
Completion of this solar system is scheduled for early August.
About GreenPointe.Energy GreenPointe.Energy is a single point of entry solution provider specializing in renewable energy development, energy procurement and energy management technologies.
Contact Info: info@greenpointeenergy.com
800-619-9880
Chester County Keystone Innovation Zone companies report more than 7 million revenue increase in last six months – 30 new jobs created and 116 jobs retained
Chester County Keystone Innovation Zone companies report more than $7 million revenue increase in last six months. ~ 30 new jobs created and 116 jobs retained
EXTON _ Fifteen of the Chester County Keystone Innovation Zone companies collectively reported more than $7 million in increased revenue for the second half of 2009. The companies also report 30 new jobs created and 116 retained.
The Chester County KIZ companies are start-up and accelerator companies that are located within the designated zone, have been in operation eight years or less and are in the bio, life sciences and technology industries. KIZ is a Department of Community and Economic Development initiative focused on the building of knowledge-based economies and the cultivation of entrepreneurship in Pennsylvania. These activities are accomplished through the gathering and aligning of resources educational institutions, private business, business support organizations, commercial lending institutions, venture capital networks and foundations.
Eligible KIZ companies have the opportunity to access a number of benefits that may be available to them at, typically, no cost. Among the benefits the companies may qualify for are KIZ specific tax credits, intern reimbursement, training reimbursement and access to translational research and grant funds.
Key partners in the Chester County KIZ include: Chester County Economic Development Council, Ben Franklin Technology Partners-Southeastern Pennsylvania, CresaPartners, Drexel University, PECO, an Exelon Corporation, Fox Rothchild LLP, Kutztown University, Liberty Property Trust, MVM Associates, Penn State University Great Valley, Pennsylvania BIO, and West Chester University.
The Chester County Economic Development Council is a private, non-profit economic development organization that has been nurturing economic growth in Chester County and the surrounding region for 50 years. The Council’s portfolio of business growth services includes: low-interest financing, small business lending, workforce training, retention and expansion, customized international business assistance, land and building site selection, brownfields consultation and remediation, urban redevelopment, and agricultural economic development. The Council also offers state-of-the art conference and training facilities at its facility in Eagleview. For more information, see www.cceconomicdevelopment.com.
Notre Dame, MTT in deal
Notre Dame, MTT in deal
Molecular Targeting Technologies Inc. has entered into a exclusive licensing deal with the University of Notre Dame for a novel sensing technology that could be used to diagnose cancer, heart disease and other medical conditions.
The technology, developed by Notre Dame professor Bradley Smith, can selectively target dead and dying mammalian cells as well as bacteria. When the targeting component is attached to a fluorescent probe for improved imaging, it has been used successfully to identify mammary and prostate tumors and bacterial infection in mice.
Terms of the agreement, signed this month, were not disclosed. This unique probe has the potential to image cell death as a means to intervene early in diseases and rapidly determine the effectiveness of treatments,” Smith said, “Imaging of cell death is broadly useful for treatment of numerous conditions, including cardiovascular diseases, neurology, renal diseases and even transplant rejection.”
Chris Pak, president and CEO of Molecular Targeting, said one of the advantages of the targeting probe is it can be used for in vitro (an artificial environment outside a Smith living organism such as a test tube) applications as well as for in vivo (in living organisms) molecular imaging.
“We believe that this technology has the potential to target myocardial ischemia, Alzheimer’s disease, cancer and bacterial infections,” Pak said. He said the technology may have therapeutic applications, but for now the company is focusing on its diagnostic use.
He said another unique feature is that the molecule it licensed can target different cell types including tumors cells, bacteria and viruses.
Dr. Brian Gray, vice president of research at Molecular Targeting, said the company is offering a range of fluorescent versions of the targeting molecule, called phosphatidylserine, for research applications under the name PSVue. The product line hit the market this week.
Founded in 2001, Molecular Targeting develops and markets small molecules used for the molecular imaging of cardio vascular diseases and cancer.
Pak started the company with two patents he developed, pertaining to the use of nuclear imaging for the rapid diagnosis of heart attack, breast cancer and stroke, while he was a researcher at Centocor in Malvern. Molecular Targeting licensed the drug-targeting technologies from Centocor, a Johnson & Johnson subsidiary now based in Horsham.
JOHN GEORGE STAFF WRITER WEST CHESTER philadelphiabusinessjoumal.com | MARCH 19-2S. 2010—
Cephalon will buy Ception Therapeutics Inc
Cephalon will buy Ception Therapeutics Inc. following the successful mid-stage clinical trial of its asthma drug candidate.
Tests showed that adults who took the drug Cinquil had greater control over their asthma, the companies said.
The companies struck an agreement in January 2009 under which Cephalon paid $100 million for an option to buy Ception at a later date.
Cephalon exercised that right and agreed to buy Ception for $250 million, plus any debt held by the company.
Ception, based in Malvern, Pa. was a privately held company.
Cinquil is an injection designed to block a type of white blood cell that is involved in allergic conditions like asthma. Cephalon said it will analyze the trial results, and then meet with regulators to discuss late-stage studies of the asthma drug.
Ception is already running late-stage trials of the drug as a treatment for pediatric eosinophilic esophagitis, a condition causes vomiting, chest pain and difficulty swallowing.
Shares of Cephalon Inc. fell 2 cents to $67.38.